Citizen Stash Cannabis Corp.
Citizen Stash Expands Ontario Market Presence with Agreement to Process Flower for Burb, a Premium Cannabis Retailer and Brand
VANCOUVER, BC / ACCESSWIRE / July 19, 2021 / Citizen Stash Cannabis Corp. (Formally Experion Holdings Ltd.) (the "Company" or "Citizen Stash") (TSXV:CSC)(OTCQB:EXPFF)(FRANKFURT:MB31) Canada's solution to craft cannabis and premium products is pleased to announce that it was granted a listing with the Ontario Cannabis Store ("OCS") to supply a new first-to-market strain under partnership with Burb brands.
Under the Burb Licensing Agreement, Citizen Stash will cultivate, source, process, package and distribute premium dried flower in 3.5 gram jars and two 0.5 gram pre-rolls under the Burb brand, beginning with the Ontario market. The first to market strain, "BC ZaZa", is a high potency THC premium flower developed internally through Citizen Stash's innovation pipeline. Citizen Stash will be the first LP in Canada to partner with and bring a retailer's flower brand to market and are proud to launch with the OCS where the popularity and demand for Citizen Stash premium flower has been well established.
"Over 40% of cannabis retailers in Canada are owned by chains and many are looking to find additional ways to unlock the revenue potential of the substantial brand equity built up in their retail operations. To that end, we feel Burb has led the charge in building one of the premier cannabis culture brands within the Canadian market and abroad, supported by a strong performing retail store portfolio in BC and backed by a passionate community of followers.
This evolution in the market opens a new and very significant opportunity for us to support select brands and retailers in launching their own in-house branded products. By leveraging our unique production capabilities, genetics, cultivation partners, custom packaging and white labelling, we can occupy more retail shelf space in a cost-effective manner, generating incremental revenue for our company and for our brand partners," commented Mr. Jarrett Malnarich, CEO of Citizen Stash.
About Citizen Stash Cannabis Corp.
Citizen Stash is the parent company of Experion Biotechnologies Inc., a Health Canada licensed cultivator and processor of Cannabis, based in Mission, B.C.
Citizen Stash is best known as a rapidly growing adult-use premium cannabis brand offered nationally in 7 provinces and territories. Citizen Stash has invested and developed a portfolio of premium cannabis genetics, strains and products with a unique growth strategy incorporating a highly scalable aggregation and distribution business model to drive revenues across its national sales network.
About Burb Cannabis Corp.
Burb is a cannabis brand bringing B.C. bud culture to the world through its network of retail stores, premium cannabis products, cut/sew apparel and a weekly podcast hosted by David Hershkovits (co-founder of PAPER Magazine). Burb honours the legacy and designs the future of cannabis culture.
This news release contains "forward-looking statements" and "forward-looking information" (collectively referred to herein as "forward-looking statements") within the meaning of applicable securities legislation. Such forward-looking statements include, without limitation, forecasts, estimates, expectations and objectives for future operations that are subject to a number of material factors, assumptions, risks and uncertainties, many of which are beyond the control of the Company.
Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "continues", "future", "forecasts", "potential", "outlook" and similar expressions, or are events or conditions that "will", "would", "may", "likely", "could", "should", "can", "typically", "traditionally" or "tends to" occur or be achieved. This news release contains forward-looking statements, pertaining to, among other things, the following: The Company's capital spending forecast and expectations of how it will be funded; near-term impacts from the COVID-19 pandemic; the Company's capital management strategy and financial position; the impact of governmental and Company measures implemented in response to the COVID-19 pandemic; the Company's outlook, activity levels, supply chains and sales channels; loss of markets; further legislative and regulatory developments involving cannabis or otherwise affecting the Company's business or its consumers generally, including delays in the issuance of licenses; competition; currency and interest rate fluctuations; and marketing costs.
Although the Company believes that the material factors, expectations and assumptions expressed in such forward-looking statements are reasonable based on information available to it on the date such statements are made, undue reliance should not be placed on the forward-looking statements because the Company can give no assurances that such statements and information will prove to be correct and such statements are not guarantees of future performance. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties.
Actual performance and results could differ materially from those currently anticipated due to a number of factors and risks. These include, but are not limited to: known and unknown risks, including those set forth in the Filing Statement dated September 25, 2017 and/or the most recent annual and interim Management's Discussion and Analysis ("MD&A") (a copy of which can be found under Experion's profile on SEDAR at www.sedar.com); a significant expansion of COVID-19 pandemic and the impacts thereof; the Company's ability to raise the necessary capital or to be fully able to implement its business strategy; integration of acquisitions, competition, and uncertainties resulting from potential delays or changes in plans with respect to acquisitions, development projects or capital expenditures and changes in legislation; stock market volatility and the inability to access sufficient capital from external and internal sources; general economic, market or business conditions including those in the event of an epidemic, natural disaster or other event; global economic events; changes to the Company's financial position and cash flow; the availability of qualified personnel, management or other key inputs; currency exchange fluctuations; changes in political and security stability; potential industry developments; and other unforeseen conditions which could impact the Company. Accordingly, readers should not place undue importance or reliance on the forward-looking statements. Readers are cautioned that the foregoing list of factors is not exhaustive and should refer to "Risk Factors" set out in the MD&A.
Statements, including forward-looking statements, contained in this news release are made as of the date they are given and the Company disclaims any intention or obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, unless so required by applicable securities laws. The forward-looking statements contained in this news release are expressly qualified by this cautionary statement.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
SOURCE: Citizen Stash Cannabis Corp.
View source version on accesswire.com:
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
Subscribe to releases from ACCESSWIRE
Subscribe to all the latest releases from ACCESSWIRE by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESSWIRE
iZafe Group14.10.2021 20:31:56 CEST | Press release
The Price for Dosell Consumer is Communicated
iZafe Group14.10.2021 14:28:43 CEST | Press release
Launch of Dosell Consumer in Italy
TECO 2030 ASA14.10.2021 09:58:48 CEST | Press release
TECO 2030 Signs Supply Frame Agreement with Chemgas Shipping
iZafe Group14.10.2021 09:41:43 CEST | Press release
Launch of Dosell Consumer in Italy
NanoViricides, Inc. 13.10.2021 12:46:57 CEST | Press release
NanoViricides, Inc. Has Filed its Annual Report: Coronavirus Drug Program Rapidly Moving Towards Clinical Stage
iZafe Group13.10.2021 09:21:42 CEST | Press release
Completion of Patents to International Markets
Physitrack13.10.2021 08:21:38 CEST | Press release
Invitation to Physitrack PLC Q3 Interim Report 2020/2021 Webcast Conference
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom